The DOI matches its Crossref record; 42 of the 45 references it cites were found in a registry or an index.
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
Abstract
apoE-deficient mice have been created by homologous recombination in ES cells. On a low fat, low cholesterol chow diet these animals have plasma cholesterol levels of 494 mg/dl compared with 60 mg/dl in control animals, and when challenged with a high fat Western-type diet, these animals have plasma cholesterol levels of 1821 mg/dl compared with 132 mg/dl in controls. This marked hypercholesterolemia is primarily due to elevated levels of very low and intermediate density lipoproteins. At 10 weeks of age, apoE-deficient mice have already developed atherosclerotic lesions in the aorta and coronary and pulmonary arteries. apoE-deficient mice are a promising small animal model to help understand the role of apoE in vivo and the genetic and environmental determinants of atherosclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The increased amounts of apoA-IV in VLDL and IDL we observed were seen in other reports of apoE deficiency4,5,9 and in apoE-deficient mice.31”
From Effects of the Absence of Apolipoprotein E on Lipoproteins, Neurocognitive Function, and Retinal Function (2014) · cites this paper as [31]
In the citing paper
“Increased amounts of apoA-I were observed in LDL from an apoE-deficient patient9 and in VLDL from ApoE knockout mice.31”
From Effects of the Absence of Apolipoprotein E on Lipoproteins, Neurocognitive Function, and Retinal Function (2014) · cites this paper as [31]
In the citing paper
“Disorders of apoE are associated with atherosclerosis, which causes dyslipidemia and myocardial infarction, and apoE-deficient mice are used as model animals for atherosclerosis2, 3).”
From Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features (2025) · cites this paper as [3]
In the citing paper
“Disorders of apoE are associated with atherosclerosis, which causes dyslipidemia and myocardial infarction, and apoE-deficient mice are used as model animals for atherosclerosis2, 3).”
From Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features (2025) · cites this paper as [3]
In the citing paper
“In vivo and in vitro studies have shown that mutations in apoE that diminish binding of apoE-containing lipoproteins to the LDL receptor are associated with high plasma cholesterol levels and cause premature atherosclerosis in humans and experimental animals ( 1-3, 7, 8 ).”
From Molecular etiology of a dominant form of type III hyperlipoproteinemia caused by R142C substitution in apoE4 (2011) · cites this paper as [1]
Citations
Cites
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
Weber, K., & Osborn, M. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94333-4 · Cited by 16,688
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
The Metabolic Basis of Inherited Disease
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-389_2 · Cited by 3,990
Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells
Thomas, K. R., & Capecchi, M. R. (1987) · Cell · doi:10.1016/0092-8674(87)90646-5 · Cited by 2,355
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Mansour, S. L., Thomas, K. R., & Capecchi, M. R. (1988) · Nature · doi:10.1038/336348a0 · Cited by 1,683
HPRT-deficient (Lesch–Nyhan) mouse embryos derived from germline colonization by cultured cells
Hooper, M., Hardy, K., Handyside, A. H., Hunter, S., & Monk, M. (1987) · Nature · doi:10.1038/326292a0 · Cited by 1,218
A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine
Powell, L. M., Wallis, S. C., Pease, R. J., Edwards, Y. H., Knott, T. J., & Scott, J. (1987) · Cell · doi:10.1016/0092-8674(87)90510-1 · Cited by 1,045
Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI
Rubin, E. M., Krauss, R. M., Spangler, E. A., Verstuyft, J. G., & Clift, S. (1991) · Nature · doi:10.1038/353265a0 · Cited by 985
Self-citation
Cited by
Sorted by citations
Items 701–800 of 1,010
Mouse model of heterotopic aortic arch transplantation
Chereshnev, I., Trogan, E., Omerhodzic, S., Itskovich, V. V., Aguinaldo, J.-G., Fayad, Z. A., Fisher, E. A. A., & Reis, E. D. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(03)00039-8 · Cited by 69
Fan, Y., Shi, F., Liu, J., Dong, J., Bui, H. H., Peake, D. A., Kuo, M., Cao, G., & Jiang, X. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.213363 · Cited by 68
Lack of predictability of classical animal models for hypolipidemic activity: a good time for mice?
Krause, B. R., & Princen, H. M. G. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00141-5 · Cited by 67
Receptor-mediated mechanisms of lipoprotein remnant catabolism
Chappell, D. A., & Medh, J. D. (1998) · Progress in Lipid Research · doi:10.1016/s0163-7827(98)00017-4 · Cited by 70
Sehayek, E., Shefer, S., Nguyen, L. B., Ono, J. G., Merkel, M., & Breslow, J. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050016197 · Cited by 69
Self-citationMolecular Advances in Cardiovascular Biology
Chien, K. R. (1993) · Science · doi:10.1126/science.8493528 · Cited by 69
Mahley, R. W., JI, Z., Brecht, W. J., Miranda, R. D., & He, D. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb44300.x · Cited by 69
O’Brien, K. D., Deeb, S. S., Ferguson, M. S., McDonald, T. O., Allen, M. D., Alpers, C. E., & Chait, A. (1994) · PubMed Central · Cited by 69
Sphingolipid Metabolism and Obesity-Induced Inflammation
Kang, S. C., Kim, B.-R., Lee, S., & Park, T. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00067 · Cited by 70
Wada, H., Ura, S., Kitaoka, S., Satoh‐Asahara, N., Horie, T., Ono, K., Takaya, T., Takanabe‐Mori, R., Akao, M., Abe, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029351 · Cited by 67
Tian, J., Pei, H., James, J. C., Li, Y., Matsumoto, A. H., Helm, G. A., & Shi, W. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.090 · Cited by 68
Layne, M. D., Patel, A. P., Chen, Y., Rebel, V. I., Carvajal, I. M., Pellacani, A. U. E., Ith, B., Zhao, D., Schreiber, B. M., Yet, S., et al. (2001) · The FASEB Journal · doi:10.1096/fj.01-0374fje · Cited by 68
Determination of the lower threshold of apolipoprotein E resulting in remnant lipoprotein clearance
Hasty, A. H., Linton, M. F., Swift, L. L., & Fazio, S. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33397-6 · Cited by 68
Apolipoprotein A-I Stimulates Secretion of Apolipoprotein E by Foam Cell Macrophages
Rees, D., Sloane, T., Jessup, W., Dean, R. T., & Kritharides, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27925 · Cited by 68
The results in rodent models of atherosclerosis are not interchangeable
Joven, J., Rull, A., Ferré, N., Escolá‐Gil, J. C., Marsillach, J., Coll, B., Alonso‐Villaverde, C., Aragonès, G., Clària, J., & Camps, J. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.06.012 · Cited by 67
The helix bundle: A reversible lipid binding motif
Narayanaswami, V., Kiss, R. S., & Weers, P. M. M. (2009) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2009.09.009 · Cited by 69
The role of endothelial mechanosensitive genes in atherosclerosis and omics approaches
Simmons, R. D., Kumar, S., & Jo, H. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.11.005 · Cited by 71
Trigatti, B. L. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00154-2 · Cited by 66
Hypomorphic Apolipoprotein E Mice
Raffaı̈, R. L., & Weisgraber, K. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111222200 · Cited by 67
Grass, D., Saini, U., Felkner, R. H., Wallace, R., Lago, W., Young, S. G., & Swanson, M. E. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39866-7 · Cited by 66
Escolá‐Gil, J. C., Julve, J., Marzal-Casacuberta, À., Ordóñez‐Llanos, J., González‐Sastre, F., & Blanco‐Vaca, F. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33441-6 · Cited by 67
Inflammation and diabetes-accelerated atherosclerosis: myeloid cell mediators
Kanter, J. E., & Bornfeldt, K. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.10.002 · Cited by 66
Ueshima, K., Akihisa-Umeno, H., Nagayoshi, A., Takakura, S., Matsuo, M., & Mutoh, S. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.247 · Cited by 66
Sildenafil restores endothelial function in the apolipoprotein E knockout mouse
Balarini, C. M., Leal, M. A. S., Gomes, I. B., Pereira, T. M. C., Gava, A. L., Meyrelles, S. S., & Vasquez, E. C. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-3 · Cited by 66
Probing myeloid cell dynamics in ischaemic heart disease by nanotracer hot-spot imaging
Senders, M. L., Meerwaldt, A. E., van Leent, M. M. T., Sánchez-Gaytán, B. L., van de Voort, J. C., Toner, Y. C., Maier, A., Klein, E. D., Sullivan, N. A. T., Sofias, A. M., et al. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0642-4 · Cited by 65
High density lipoprotein, apolipoprotein A-1, and coronary artery disease
Srivastava, R., & Srivastava, N. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007111830472 · Cited by 65
Roux, D. T., Roullot, V., Schweitzer, A., Berthier, R., & Marguerie, G. A. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.6.2141 · Cited by 67
Metabonomic Changes Associated with Atherosclerosis Progression for LDLR–/– Mice
Li, D., Zhang, L., Dong, F., Liu, Y., Li, N., Li, H., Lei, H., Hao, F., Wang, Y., Zhu, Y., et al. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00032 · Cited by 65
Çilingiroğlu, M., Oh, J., Sugunan, B., Kemp, N. J., Kim, J., Lee, S., Zaatari, H. N., Escobedo, D., Thomsen, S., Milner, T. E., et al. (2006) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.20717 · Cited by 65
Chistiakov, D. A., Orekhov, A. N., & Bobryshev, Y. V. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.05.010 · Cited by 66
Complete Atherosclerosis Regression After Human ApoE Gene Transfer in ApoE-Deficient/Nude Mice
Desurmont, C., Caillaud, J., Emmanuel, F., Benoit, P., Fruchart, J., Castro, G. R., Branellec, D., Heard, J., & Duverger, N. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.2.435 · Cited by 65
Hyperlipidemia Disrupts Cerebrovascular Reflexes and Worsens Ischemic Perfusion Defect
Ayata, C., Shin, H. K., Dileköz, E., Atochin, D. N., Kashiwagi, S., Eikermann‐Haerter, K., & Huang, P. L. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.38 · Cited by 64
Milad, N., White, Z. R., Tehrani, A. Y., Sellers, S., Rossi, F. M. V., & Bernatchez, P. N. (2017) · Skeletal Muscle · doi:10.1186/s13395-017-0135-9 · Cited by 60
Reckless, J., Rubin, E. M., Verstuyft, J. B., Metcalfe, J. C., & Grainger, D. J. (1999) · Circulation · doi:10.1161/01.cir.99.17.2310 · Cited by 64
Self-citationSchwiegelshohn, B., Presley, J. F., Gorecki, M., Vogel, T., Carpentier, Y., Maxfield, F. R., & Deckelbaum, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.4.1761 · Cited by 64
Beyond vascular inflammation—recent advances in understanding atherosclerosis
Wolf, D., Zirlik, A., & Ley, K. F. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1971-6 · Cited by 62
Genetically modified pigs to model human diseases
Flisikowska, T., Kind, A., & Schnieke, A. (2013) · Journal of Applied Genetics · doi:10.1007/s13353-013-0182-9 · Cited by 63
Marathe, S. V., Choi, Y., Leventhal, A. R., & Tabas, I. A. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.12.2607 · Cited by 63
The Roles of Cholesterol and Its Metabolites in Normal and Malignant Hematopoiesis
Oguro, H. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00204 · Cited by 73
Chernick, D., Ortiz‐Valle, S., Jeong, A., Qu, W., & Li, L. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134306 · Cited by 64
Keidar, S., Attias, J., Coleman, R., WIRTH, K. J., Schölkens, B. A., & Hayek, T. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200001000-00008 · Cited by 63
Self-citationLocalization, physiology, and modulation of a molluskan dopaminergic synapse
Magoski, N. S., & Bulloch, A. G. M. (1997) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(199709)33:3 · Cited by 19
Martins, I. J., Sainsbury, A., Mamo, J. C. L., & Redgrave, T. G. (1994) · Diabetologia · doi:10.1007/bf00398049 · Cited by 63
Shamir, R., Shehadeh, N., Rosenblat, M., Eshach‐Adiv, O., Coleman, R., Kaplan, M., Hamoud, S., Lischinsky, S., & Hayek, T. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000042232.42883.56 · Cited by 63
Self-citationHiebert, P., Wu, D., & Granville, D. J. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.96 · Cited by 62
Hung, M., Zhang, Z. J., Li, S., Lei, B., Yuan, S., Cui, G., Hoi, M. P. M., Chan, K., & Lee, S. M. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/605303 · Cited by 63
Champagne, D. L., Dupuy, J.-B., Rochford, J. M., & Poirier, J. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00313-5 · Cited by 64
New insights into immunological aspects of atherosclerosis
Jawień, J. (2008) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.332 · Cited by 62
Hager, L., Li, L., Pun, H., Liu, L., Hossain, M. A., Maguire, G. F., Naples, M., Baker, C., Magomedova, L., Tam, J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.340919 · Cited by 63
Cardiac and vascular changes in elderly atherosclerotic mice: the influence of gender
Pereira, T. D. M. C., Nogueira, B. V., Freitas‐Lima, L. C., Porto, M. L., Arruda, J. A., Vasquez, E. C., & Meyrelles, S. S. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-87 · Cited by 61
Diabetes and Arterial Extracellular Matrix Changes in a Porcine Model of Atherosclerosis
McDonald, T. O., Gerrity, R. G., Jen, C., Chen, H.-J., Wark, K., Wight, T. N., Chait, A., & O’Brien, K. D. (2007) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.7a7221.2007 · Cited by 61
Macrophage fatty acid oxidation inhibits atherosclerosis progression
Nomura, M., Liu, J., Yu, Z., Yamazaki, T., Yan, Y., Kawagishi, H., Rovira, I. I., Liu, C., Wolfgang, M. J., Mukouyama, Y., et al. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.01.003 · Cited by 61
Fan, J. J., Liu, L., Liu, Q., Cui, Y., Yao, B., Zhang, M., Gao, Y., Fu, Y., Dai, H., Pan, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07895-3 · Cited by 62
Targeting cellular cholesterol for anticancer therapy
Gu, L., Saha, S. T., Thomas, J., & Kaur, M. (2019) · FEBS Journal · doi:10.1111/febs.15018 · Cited by 63
Apolipoprotein E Inhibits Neointimal Hyperplasia after Arterial Injury in Mice
Zhu, B., Kuhel, D. G., Witte, D. P., & Hui, D. Y. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64823-7 · Cited by 61
Knopp, E. A., Arndt, T. L., Eng, K., Caldwell, M., LeBoeuf, R. C., Deeb, S. S., & O’Brien, K. D. (1999) · Mammalian Genome · doi:10.1007/s003359901053 · Cited by 61
Expression of lipoprotein receptors in atherosclerotic lesions
Hiltunen, T. P., & Ylä‐Herttuala, S. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00307-9 · Cited by 60
Hartley, C. J., Reddy, A. K., Madala, S., Michael, L. H., Entman, M. L., & Taffet, G. E. (2007) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2006.11.002 · Cited by 60
Glaros, E. N., Kim, W. S., Quinn, C. M., Jessup, W., Rye, K., & Garner, B. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700261-jlr200 · Cited by 60
Apolipoprotein E and its role in aging and survival
Bonomini, F., Filippini, F., Hayek, T., Aviram, M., Keidar, S., Rodella, L. F., Coleman, R., & Rezzani, R. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.11.006 · Cited by 60
Self-citationHeinonen, S. E., Leppänen, P., Kholová, I., Lumivuori, H., Häkkinen, S.-K., Bosch, F., Laakso, M., & Ylä‐Herttuala, S. (2007) · Circulation Research · doi:10.1161/circresaha.107.154401 · Cited by 60
Kypreos, K. E., Karagiannides, I., Fotiadou, E. H., Karavia, E. A., Brinkmeier, M. S., Giakoumi, S. M., & Tsompanidi, E. M. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07301.x · Cited by 61
Increased glycosphingolipid levels in serum and aortae of apolipoprotein E gene knockout mice
Garner, B., Priestman, D. A., Stocker, R., Harvey, D. J., Butters, T. D., & Platt, F. M. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30162-0 · Cited by 60
Srivastava, R. A. K., Srivastava, N., & Averna, M. R. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2000.01473.x · Cited by 60
Apolipoprotein E and Alzheimer's Disease: A Review of Recent Studies
Higgins, G. A., Large, C. H., Rupniak, H. T., & Barnes, J. C. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00420-0 · Cited by 58
Molecular and cellular concepts in atherosclerosis
Sanders, M. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90060-4 · Cited by 60
Whitman, S. C., Miller, D. B., Wolfe, B. M., Hegele, R. A., & Huff, M. W. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.9.1707 · Cited by 59
Zhu, Z., Hua, B., Shang, Z., Yuan, G., Xu, L., Li, E., Li, X., Sun, N., Yan, Z., Qian, R., et al. (2016) · BioMed Research International · doi:10.1155/2016/5438589 · Cited by 60
Quantitative Assay for Mouse Atherosclerosis in the Aortic Root
Baglione, J., & Smith, J. D. (2006) · Humana Press eBooks · doi:10.1385/1-59745-213-0:83 · Cited by 59
Self-citationChronic Stress Accelerates Atherosclerosis in the Apolipoprotein E Deficient Mouse
Meena Kumari, B., Grahame-Clarke, C. N., Shanks, N. M., Marmot, M. G., Lightman, S. L., & Vallance, P. J. (2003) · Stress · doi:10.1080/10253890310001619461 · Cited by 59
Diabetes‐mediated myelopoiesis and the relationship to cardiovascular risk
Barrett, T. J., Murphy, A. J., Goldberg, I. J., & Fisher, E. A. A. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13462 · Cited by 60
Acute Loss of Apolipoprotein E Triggers an Autoimmune Response That Accelerates Atherosclerosis
Centa, M., Prokopec, K. E., Garimella, M. G., Habir, K., Hofste, L., Stark, J. M., Dahdah, A., Tibbitt, C. A., Polyzos, K. A., Gisterå, A., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.310802 · Cited by 59
Promoting the Delivery of Nanoparticles to Atherosclerotic Plaques by DNA Coating
Zhang, L., Tian, X. Y., Chan, C. K. W., Bai, Q., Cheng, C. K., Chen, F. M., Cheung, M. S. H., Yin, B., Yang, H., Yung, W., et al. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b17928 · Cited by 59
Swertfeger, D. K., & Hui, D. Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102357200 · Cited by 59
Genetically modified mice for the study of apolipoprotein B
Kim, E. J.-H., & Young, S. G. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32560-8 · Cited by 59
Homozygous Familial Defective Apolipoprotein B-100
Schaefer, J. R., Scharnagl, H., Baumstark, M. W., Schweer, H., Zech, L. A., Seyberth, H. J., Winkler, K., Steinmetz, A., & März, W. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.2.348 · Cited by 59
Amigo, L., Quiñones, V., Mardones, P., Zanlungo, S., Miquel, J. F., Nervi, F. O., & Rigotti, A. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70147-8 · Cited by 59
Henninger, D. D., Gerritsen, M. E., & Granger, D. N. (1997) · Circulation Research · doi:10.1161/01.res.81.2.274 · Cited by 59
Stevenson, S. C., Marshall-Neff, J., Teng, B., Lee, C. B., Roy, S., & McClelland, A. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.4.479 · Cited by 59
Ishigaki, Y., Oikawa, S., Suzuki, T., Usui, S., Magoori, K., Kim, D.-H., Suzuki, H., Sasaki, J., Sasano, H., Okazaki, M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005906200 · Cited by 58
Type III hyperlipoproteinemic phenotype in transgenic mice expressing dysfunctional apolipoprotein E
Fazio, S., Lee, Y. L., Ji, Z. S., & Rall, S. C. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116728 · Cited by 71
Domains of Apolipoprotein E Contributing to Triglyceride and Cholesterol Homeostasis in Vivo
Kypreos, K. E., van Dijk, K. W., van der Zee, A., Havekes, L. M., & Zannis, V. I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100418200 · Cited by 62
Remodeling of the Neurovascular Unit Following Cerebral Ischemia and Hemorrhage
Satō, Y., Falcone-Juengert, J., Tominaga, T., Su, H., & Liu, J. (2022) · Cells · doi:10.3390/cells11182823 · Cited by 60
Endosialin Promotes Atherosclerosis Through Phenotypic Remodeling of Vascular Smooth Muscle Cells
Hasanov, Z., Ruckdeschel, T., König, C., Mogler, C., Kapel, S. S., Korn, C., Spegg, C., Eichwald, V., Wieland, M. J., Appak‐Baskoy, S., et al. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308455 · Cited by 58
Idel, S., Dansky, H. M., & Breslow, J. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1835672100 · Cited by 58
Self-citationProbing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer
Zannis, V. I., Chroni, A., Kypreos, K. E., Kan, H.-Y., Cesar, T. B., Zanni, E. E., & Kardassis, D. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200404000-00008 · Cited by 74
Slätis, K., Gåfvels, M. E., Kannisto, K., Овчинникова, О. А., Paulsson‐Berne, G., Parini, P., Jiang, Z., & Eggertsen, G. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m009308 · Cited by 57
Regulation of cholesterol homeostasis by liver X receptors
Hu, Y., Zheng, L., & Wang, Q. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.12.027 · Cited by 57
In vitro models of aortic valve calcification: solidifying a system
Bowler, M. A., & Merryman, W. D. (2014) · Cardiovascular Pathology · doi:10.1016/j.carpath.2014.08.003 · Cited by 60
Jin, S., Shen, L., Nie, P., Yuan, W., Hu, L., Li, D., Chen, X., Zhang, X.-K., & He, B. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.236158 · Cited by 57
Endothelial dysfunction and atherosclerosis: Endothelin receptor antagonists as novel therapeutics
Barton, M. (2000) · Current Hypertension Reports · doi:10.1007/s11906-000-0064-5 · Cited by 57
Reconstituted Discoidal ApoE-Phospholipid Particles Are Ligands for the Scavenger Receptor BI
Li, X., Kan, H.-Y., Lavrentiadou, S. N., Krieger, M., & Zannis, V. I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200658200 · Cited by 57
Autoimmunity in atherosclerosis: lessons from experimental models
George, J., Afek, A. B., Gilburd, B., Harats, D., & Shoenfeld, Y. (2000) · Lupus · doi:10.1191/096120300678828190 · Cited by 57
Manka, D. R., Wiegman, P., Din, S., Sanders, J. M., Green, S. A., Gimple, L. W., Ragosta, M., Powers, E. R., Ley, K. F., & Sarembock, I. J. (1999) · Journal of Vascular Research · doi:10.1159/000025676 · Cited by 57
Calingasan, N. Y., Gandy, S., Baker, H., Sheu, K. R., Smith, J. D., Lamb, B. T., Gearhart, J. D., Buxbaum, J. D., Harper, C. C., Selkoe, D. J., et al. (1996) · Europe PMC (PubMed Central) · Cited by 56
Self-citationIncreased 3-nitrotyrosine in brains of Apo E-deficient mice
Matthews, R. T., & Beal, M. F. (1996) · Brain Research · doi:10.1016/0006-8993(95)01576-0 · Cited by 57
Watkins, A. A., Yasuda, K., Wilson, G. E., Aprahamian, T. R., Xie, Y., Maganto-García, E., Shukla, P., Oberlander, L., Laskow, B., Menn‐Josephy, H., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402807 · Cited by 57
The F11 receptor (F11R/JAM-A) in atherothrombosis: Overexpression of F11R in atherosclerotic plaques
Babińska, A., Azari, B. M., Salifu, M., Liu, R., Jiang, X., Sobocka, M. B., Boo, D., Khoury, G., Deitch, J. S., Marmur, J. D., et al. (2007) · Thrombosis and Haemostasis · doi:10.1160/th06-08-0454 · Cited by 56
Characterization of Nuclear Sirtuins: Molecular Mechanisms and Physiological Relevance
Toiber, D., Sebastián, C., & Mostoslavsky, R. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-21631-2_9 · Cited by 57
Sphingolipids and atherosclerosis
Hornemann, T., & Worgall, T. S. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.08.041 · Cited by 60
Metadata
- Authors
- Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L.
- Affiliations
- Rockefeller University (US)
- Lawrence Berkeley National Laboratory (US)
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1992-10
- Volume
- 71
- Issue
- 2
- Pages
- 343-353
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2048890665
- Cited by
- 2,263
- References
- 45
- Citations by year
- 2026: 23 · 2025: 41 · 2024: 28 · 2023: 32 · 2022: 52 · 2021: 39 · 2020: 60 · 2019: 69 · 2018: 57 · 2017: 66 · 2016: 57 · 2015: 71 · 2014: 71 · 2013: 82 · 2012: 75
- FWCI
- 72.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl033714-17)
- National Heart, Lung, and Blood Institute (HL 33714, R01HL032435, HL32435)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- apolipoprotein E deficiency, hypercholesterolemia, atherosclerosis, ApoE-deficient mice, homologous recombination, embryonic stem cells, serum cholesterol, VLDL, intermediate density lipoprotein, high-fat diet, aortic atherosclerotic lesions, coronary arteries, pulmonary artery, animal models of atherosclerosis
- MeSH terms
- Animals, Aorta, Apolipoproteins E, Arteriosclerosis, Cholesterol, Coronary Vessels, Disease Models, Animal, Hypercholesterolemia, Lipoproteins, Lipoproteins, VLDL, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Transgenic, Pulmonary Artery, Stem Cells, Mice, Lipoproteins, IDL
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review